SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer – ANNALS OF ONCOLOGY

Borghaei, H; de Marinis, F; Dumoulin, D; Reynolds, C; Theelen, WSME; Percent, I; Calderon, VG; Johnson, ML; Madroszyk-Flandin, A; Garon, EB; He, K; Planchard, D; Reck, M; Popat, S; Herbst, RS; Leal, TA; Shazer, RL; Yan, X; Harrigan, R; Peters, S – 2024 – 10.1016/j.annonc.2023.10.004